Literature DB >> 25670494

Exogenous Superoxide Dismutase Mimetic Without Scavenging H2O2 Causes Photoreceptor Damage in a Rat Model for Oxygen-Induced Retinopathy.

Shamin Jivabhai Patel1, Fayez Bany-Mohammed1, Lois McNally2, Gloria B Valencia3, Douglas R Lazzaro2, Jacob V Aranda4, Kay D Beharry4.   

Abstract

PURPOSE: Frequent, brief intermittent episodes of hypoxia (IH) during hyperoxia increase reactive oxygen species in the immature retina with compromised antioxidant systems, thus leading to oxygen-induced retinopathy (OIR). We examined the hypothesis that early exposure to a mimetic of superoxide dismutase (SOD), the first line of defense against oxidative stress, will decrease IH-induced reactive oxygen species (ROS) and prevent severe OIR in our rat model.
METHODS: To test this hypothesis, newborn rats (P0) were exposed to IH consisting of alternating cycles of 50% O₂ with brief hypoxia (12% O₂) until P14 during which they were treated with a single daily intraperitoneal (IP) dose of MnTBAP (a SOD mimetic) at 1.0, 5.0, or 10.0 mg/kg on P0, P1, and P2. A saline-treated group served as vehicle controls. Groups were analyzed following IH at P14 or allowed to recover in room air (RA) until P21. Control littermates were raised in RA with all conditions identical except for inspired O₂. Ocular assessment of OIR severity, oxidative stress, angiogenesis, antioxidant activity, and oxidative phosphorylation (OXPHOS) were conducted at P14 and P21.
RESULTS: Collectively, the data show increased oxidative stress and angiogenesis with MnTBAP, which was associated with photoreceptor damage, retinal characteristics consistent with severe OIR, and changes in genes regulating OXPHOS.
CONCLUSIONS: In the setting of IH, the use of exogenous SOD mimetics must be combined with H₂O₂ scavengers in order to prevent photoreceptor damage and severe OIR. Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  antioxidants; intermittent hypoxia; oxygen-induced retinopathy; retina

Mesh:

Substances:

Year:  2015        PMID: 25670494      PMCID: PMC4354243          DOI: 10.1167/iovs.14-15321

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  52 in total

1.  Extension of life-span with superoxide dismutase/catalase mimetics.

Authors:  S Melov; J Ravenscroft; S Malik; M S Gill; D W Walker; P E Clayton; D C Wallace; B Malfroy; S R Doctrow; G J Lithgow
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

2.  The rod photoreceptors in retinopathy of prematurity: an electroretinographic study.

Authors:  A B Fulton; R M Hansen; R A Petersen; D K Vanderveen
Journal:  Arch Ophthalmol       Date:  2001-04

Review 3.  Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia.

Authors:  Robert D Guzy; Paul T Schumacker
Journal:  Exp Physiol       Date:  2006-07-20       Impact factor: 2.969

4.  Cell-specific expression of manganese superoxide dismutase protein in the lungs of patients with respiratory distress syndrome, chronic lung disease, or persistent pulmonary hypertension.

Authors:  T M Asikainen; P Heikkilä; R Kaarteenaho-Wiik; V L Kinnula; K O Raivio
Journal:  Pediatr Pulmonol       Date:  2001-09

5.  Reactive oxygen species accelerate production of vascular endothelial growth factor by advanced glycation end products in RAW264.7 mouse macrophages.

Authors:  Yoshishige Urata; Michiko Yamaguchi; Yasuhito Higashiyama; Yoshito Ihara; Shinji Goto; Michihiko Kuwano; Seikoh Horiuchi; Koji Sumikawa; Takahito Kondo
Journal:  Free Radic Biol Med       Date:  2002-04-15       Impact factor: 7.376

6.  Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics.

Authors:  S Melov; S R Doctrow; J A Schneider; J Haberson; M Patel; P E Coskun; K Huffman; D C Wallace; B Malfroy
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

7.  Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite.

Authors:  Xiaolin Gu; Azza B El-Remessy; Steven E Brooks; Mohamed Al-Shabrawey; Nai-Tsi Tsai; Ruth B Caldwell
Journal:  Am J Physiol Cell Physiol       Date:  2003-05-07       Impact factor: 4.249

Review 8.  Pathogenesis of retinopathy of prematurity.

Authors:  Lois E H Smith
Journal:  Growth Horm IGF Res       Date:  2004-06       Impact factor: 2.372

9.  Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants.

Authors:  Jackie R York; Susan Landers; Russell S Kirby; Patrick G Arbogast; John S Penn
Journal:  J Perinatol       Date:  2004-02       Impact factor: 2.521

10.  Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?

Authors:  Lily C Chow; Kenneth W Wright; Augusto Sola
Journal:  Pediatrics       Date:  2003-02       Impact factor: 7.124

View more
  14 in total

Review 1.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

2.  Oxidative stress upregulates Wnt signaling in human retinal microvascular endothelial cells through activation of disheveled.

Authors:  Chi Zhang; Elizabeth Tannous; Jie J Zheng
Journal:  J Cell Biochem       Date:  2019-04-08       Impact factor: 4.429

3.  MnTBAP or Catalase Is More Protective against Oxidative Stress in Human Retinal Endothelial Cells Exposed to Intermittent Hypoxia than Their Co-Administration (EUK-134).

Authors:  Michelle Quan; Charles L Cai; Gloria B Valencia; Jacob V Aranda; Kay D Beharry
Journal:  React Oxyg Species (Apex)       Date:  2017-01-01

4.  Chronic Intermittent Hypoxia Causes Lipid Peroxidation and Altered Phase 1 Drug Metabolizing Enzymes in the Neonatal Rat Liver.

Authors:  Charles Cai; Jacob V Aranda; Gloria B Valencia; Jiliu Xu; Kay D Beharry
Journal:  React Oxyg Species (Apex)       Date:  2017-05-01

5.  Neonatal Intermittent Hypoxia, Reactive Oxygen Species, and Oxygen-Induced Retinopathy.

Authors:  Kay D Beharry; Charles L Cai; Gloria B Valencia; Arwin M Valencia; Douglas R Lazzaro; Fayez Bany-Mohammed; Jacob V Aranda
Journal:  React Oxyg Species (Apex)       Date:  2017-01

6.  Impact of Chronic Neonatal Intermittent Hypoxia on Severity of Retinal Damage in a Rat Model of Oxygen-Induced Retinopathy.

Authors:  Kay D Beharry; Charles L Cai; Taimur Ahmad; Sibel Guzel; Gloria B Valencia; Jacob V Aranda
Journal:  J Nat Sci       Date:  2018

7.  Ocular Adverse Effects of Intravitreal Bevacizumab Are Potentiated by Intermittent Hypoxia in a Rat Model of Oxygen-Induced Retinopathy.

Authors:  Jeffrey J Tan; Charles L Cai; Eric M Shrier; Lois McNally; Douglas R Lazzaro; Jacob V Aranda; Kay D Beharry
Journal:  J Ophthalmol       Date:  2017-07-09       Impact factor: 1.909

8.  Pharmacologic synergism of ocular ketorolac and systemic caffeine citrate in rat oxygen-induced retinopathy.

Authors:  Jacob V Aranda; Charles L Cai; Taimur Ahmad; Vadim Bronshtein; Jonathan Sadeh; Gloria B Valencia; Douglas R Lazzaro; Kay D Beharry
Journal:  Pediatr Res       Date:  2016-05-16       Impact factor: 3.756

9.  Differentially expressed miRNAs in oxygen‑induced retinopathy newborn mouse models.

Authors:  Yunpeng Wang; Suying Wu; Yang Yang; Fen Peng; Qintao Li; Peng Tian; Erying Xiang; Honglu Liang; Beibei Wang; Xiaoyu Zhou; Hua Huang; Xiaoguang Zhou
Journal:  Mol Med Rep       Date:  2016-12-06       Impact factor: 2.952

Review 10.  Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss.

Authors:  Joanna Kadłubowska; Lucia Malaguarnera; Piotr Wąż; Katarzyna Zorena
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.